138 related articles for article (PubMed ID: 32742498)
1. Value of combining PET/CT and clinicopathological features in predicting EGFR mutation in Lung Adenocarcinoma with Bone Metastasis.
Yao G; Zhou Y; Gu Y; Wang Z; Yang M; Sun J; Luo Q; Zhao H
J Cancer; 2020; 11(18):5511-5517. PubMed ID: 32742498
[No Abstract] [Full Text] [Related]
2. Value of
Lv Z; Fan J; Xu J; Wu F; Huang Q; Guo M; Liao T; Liu S; Lan X; Liao S; Geng W; Jin Y
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):735-750. PubMed ID: 29164298
[TBL] [Abstract][Full Text] [Related]
3. [Evaluate the value of (18)F-FDG PET-CT imaging in predicting the mutationsin epidermal growth factor receptor in lung adenocarcinoma].
Ding CY; Yang WP; Guo Z; Sun J; Li YY; Li TR
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):528-531. PubMed ID: 28728300
[No Abstract] [Full Text] [Related]
4. Correlations Study Between
Yang B; Wang QG; Lu M; Ge Y; Zheng YJ; Zhu H; Lu G
Front Oncol; 2019; 9():589. PubMed ID: 31380265
[No Abstract] [Full Text] [Related]
5. Correlation between EGFR mutation status and F
Zhu L; Yin G; Chen W; Li X; Yu X; Zhu X; Jiang W; Jia C; Chen P; Zhang Y; Lu D; Yu L; Li X; Xu W
Thorac Cancer; 2019 Apr; 10(4):659-664. PubMed ID: 30776196
[TBL] [Abstract][Full Text] [Related]
6.
Gao XC; Wei CH; Zhang RG; Cai Q; He Y; Tong F; Dong JH; Wu G; Dong XR
Oncol Lett; 2020 Oct; 20(4):61. PubMed ID: 32863894
[TBL] [Abstract][Full Text] [Related]
7. Association between cigarette smoking history, metabolic phenotypes, and
Zhang X; Guo X; Gao Q; Zhang J; Zheng J; Zhao G; Okuda K; Tartarone A; Jiang M
J Thorac Dis; 2023 Oct; 15(10):5689-5699. PubMed ID: 37969305
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of
Wang J; Wen X; Yang G; Cui Y; Hao M; Qiao X; Jin B; Li B; Wu J; Li X; Ren X
Transl Cancer Res; 2022 Jul; 11(7):2338-2347. PubMed ID: 35966305
[TBL] [Abstract][Full Text] [Related]
9. Value of combining serum carcinoembryonic antigen and PET/CT in predicting
Gu J; Xu S; Huang L; Li S; Wu J; Xu J; Feng J; Liu B; Zhou Y
J Thorac Dis; 2018 Feb; 10(2):723-731. PubMed ID: 29607142
[TBL] [Abstract][Full Text] [Related]
10. CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma.
Shen TX; Liu L; Li WH; Fu P; Xu K; Jiang YQ; Pan F; Guo Y; Zhang MC
Cancer Imaging; 2019 Jun; 19(1):34. PubMed ID: 31174617
[TBL] [Abstract][Full Text] [Related]
11. Biological Significance of
Wang Y; Han R; Wang Q; Zheng J; Lin C; Lu C; Li L; Chen H; Jin R; He Y
Int J Gen Med; 2021; 14():347-356. PubMed ID: 33568935
[TBL] [Abstract][Full Text] [Related]
12. Identification of EGFR mutation status in male patients with non-small-cell lung cancer: role of
Jiang M; Chen P; Guo X; Zhang X; Gao Q; Zhang J; Zhao G; Zheng J
EJNMMI Res; 2023 Apr; 13(1):27. PubMed ID: 37014455
[TBL] [Abstract][Full Text] [Related]
13. Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation.
Lee EY; Khong PL; Lee VH; Qian W; Yu X; Wong MP
Clin Nucl Med; 2015 Mar; 40(3):e190-5. PubMed ID: 25608155
[TBL] [Abstract][Full Text] [Related]
14. Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT.
Choi H; Paeng JC; Kim DW; Lee JK; Park CM; Kang KW; Chung JK; Lee DS
Lung Cancer; 2013 Mar; 79(3):242-7. PubMed ID: 23261227
[TBL] [Abstract][Full Text] [Related]
15. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
[TBL] [Abstract][Full Text] [Related]
16. The relationship of PET/CT SUVmax with EGFR mutation status and ALK rearrangement in lung adenocarcinoma.
Igde MH; Ozturk A; Oruc O; Oztas S; Kavas M
Hell J Nucl Med; 2022; 25(2):188-195. PubMed ID: 36030461
[TBL] [Abstract][Full Text] [Related]
17.
Salazar A; JĂșnior EP; Salles PGO; Silva-Filho R; Reis EA; Mamede M
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):855-863. PubMed ID: 30143840
[TBL] [Abstract][Full Text] [Related]
18.
Yang B; Ji HS; Zhou CS; Dong H; Ma L; Ge YQ; Zhu CH; Tian JH; Zhang LJ; Zhu H; Lu GM
Transl Lung Cancer Res; 2020 Jun; 9(3):563-574. PubMed ID: 32676320
[TBL] [Abstract][Full Text] [Related]
19. Clinicoradiological features associated with epidermal growth factor receptor exon 19 and 21 mutation in lung adenocarcinoma.
Zhao FN; Zhao YQ; Han LZ; Xie YS; Liu Y; Ye ZX
Clin Radiol; 2019 Jan; 74(1):80.e7-80.e17. PubMed ID: 30591175
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.
Wang D; Zhang M; Gao X; Yu L
PLoS One; 2016; 11(6):e0158307. PubMed ID: 27336755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]